PUBLISHER: The Business Research Company | PRODUCT CODE: 1973507
PUBLISHER: The Business Research Company | PRODUCT CODE: 1973507
Femtech refers to technology supporting women's health through software, diagnostics, products, and services designed to meet female biological needs.
The main types of femtech encompass devices, software, services, and others. Devices in femtech represent a broad array of tools and products designed for improving women's health. This category includes wearable devices, treatment devices, and various other products tailored to women's health needs. Software in femtech is employed in female-oriented technological products that focus on women's wellness and healthcare. Services within femtech include medical services utilized in women's healthcare, which can involve therapy services dedicated to wellness and healthcare. Femtech serves various end-users, including direct-to-consumer platforms, hospitals, fertility clinics, surgical centers, and diagnostic centers. The applications of femtech cover a range of women's health areas, including reproductive health, pregnancy and nursing care, pelvic and uterine healthcare, general healthcare and wellness, among others.
Tariffs have influenced the femtech market by increasing costs of imported wearable devices, diagnostic tools, and electronic components. These cost pressures are more evident in device based segments across asia pacific and north america. Software and mobile application offerings remain largely insulated from direct tariff impacts. Higher tariffs have encouraged regional manufacturing of health devices. This trend is supporting localized innovation and improved supply chain resilience.
The femtech market research report is one of a series of new reports from The Business Research Company that provides femtech market statistics, including femtech industry global market size, regional shares, competitors with a femtech market share, detailed femtech market segments, market trends and opportunities, and any further data you may need to thrive in the femtech industry. This femtech market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The femtech market size has grown exponentially in recent years. It will grow from $46.47 billion in 2025 to $55.88 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to rising awareness of women health issues, smartphone health app adoption, growth of digital health platforms, early fertility tracking tools, increasing healthcare spending.
The femtech market size is expected to see exponential growth in the next few years. It will grow to $118.99 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to precision medicine adoption, AI driven health insights, expansion of telehealth services, wearable device innovation, rising investment in women focused startups. Major trends in the forecast period include personalized women health platforms, digital fertility tracking, remote prenatal monitoring, wearable health devices for women, telehealth based gynecology services.
Growing healthcare spending is driving the femtech market. Healthcare spending, which encompasses expenditures by individuals, governments, and organizations on healthcare goods and services, fuels investment in research, development, and adoption of innovative women's health technologies. This, in turn, enhances access to advanced products and services for women's health and well-being. For instance, according to the National Health Expenditures Accounts (NHEA) by KFF, a US-based health policy research organization, healthcare spending in the USA is projected to rise by 5% from 2023 to 2024, reaching $4.9 trillion. Thus, the increase in healthcare spending is boosting the femtech market.
Major companies in the femtech market are focusing on developing advanced solutions, such as consumer insights and research platforms, to drive innovation in women's health. These platforms collect, analyze, and interpret consumer data to understand preferences, behaviors, and trends, helping businesses make informed decisions and tailor products effectively. For instance, in June 2024, Unfabled, a UK-based women's health platform, launched Unfabled Labs, a consumer insights and research platform leveraging data from over 400,000 women and non-binary individuals to address the gender health gap and inform the development of tailored products and services.
In March 2023, Maven Clinic, a US-based provider of virtual maternity and women's health services, acquired Naytal, a UK-based femtech solutions provider, for an undisclosed amount. This acquisition enabled Maven Clinic to expand its fertility and family care services by integrating Naytal's personalized fertility and pregnancy planning programs into its digital health platform.
Major companies operating in the femtech market are Totohealth Inc.; LifeSense Group; Lumenis Ltd.; Maven Clinic; Kindbody Fertility & Women's Health; Flo Health Inc.; Minvera Health Inc.; Natural Cycles; NURX Inc.; BioWink GmbH; Elvie Inc.; Nuvo Group LLC; Lia Diagnostics Inc.; Bloomlife Inc.; Kasha Global Inc.; Proov; Athena Feminine Technologies; Ava Science Inc.; Joylux Inc.; MedAnswers; OCON Healthcare LLC; Flyte by Pelvital; Inne Inc.; Tia Health; Gennev; iSono Health Inc.; OOVA Inc.; Sera Prognostics Inc.; Cora Health Inc.; HeraMED Inc.; Sustain Natural; LactApp Women's Health; Trak Fertility; Willow Pump Company; Yono Labs; Zava
North America was the largest region in the femtech market in 2025. The regions covered in the femtech market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the femtech market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The femtech market includes revenues earned by entities by providing period tracker, fertility tracking and solutions, menstruation products, prenatal and postnatal care products, and reproduction healthcare products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Femtech Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses femtech market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for femtech ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The femtech market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.